Indeed, inhibition of lactate production through targeting LDHA has shown significant benefits in multiple cancers (Feng et al., 2018), including melanoma, lung cancer, breast cancer, cervical cancer, leukemia, glioma, and adrenal cancer. The gene discussed is LDHA; the disease is breast carcinoma.